Unmet Needs in Retinal Disease Therapeutics

Challenges and innovations in clinical endpoints and therapeutics for retinal diseases, with a focus on glaucoma and retinal ganglion cell neuroprotection.

THE OPHTHALMOLOGY MEDICINES COMPANY Unmet needs in clinical endpoints and therapeutics for retinal diseases: challenges and innovations Glaucoma and retinal ganglion cell neuroprotection as a case study